XOSPATA Presentation
Loading Map....
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients
PRESENTER
HAIFAA ABDULHAQ
RSVP by 8/20/19 to Melba Vasquez
(925) 520-5947
melba.vasquez@astellas.com